Unrecognized Tax Benefits of Travere Therapeutics, Inc. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Travere Therapeutics, Inc. quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • Travere Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending 31 Dec 2025 was $26,031,000, a 5% decline year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

Travere Therapeutics, Inc. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $26,031,000 -$1,373,000 -5% 31 Dec 2025 10-K 19 Feb 2026 2025 FY
Q4 2024 $27,404,000 +$4,498,000 +20% 31 Dec 2024 10-K 19 Feb 2026 2025 FY
Q4 2023 $22,906,000 +$11,416,000 +99% 31 Dec 2023 10-K 19 Feb 2026 2025 FY
Q4 2022 $11,490,000 +$3,665,000 +47% 31 Dec 2022 10-K 19 Feb 2026 2025 FY
Q4 2021 $7,825,000 +$2,632,000 +51% 31 Dec 2021 10-K 21 Feb 2025 2024 FY
Q4 2020 $5,193,000 +$4,958,000 +2110% 31 Dec 2020 10-K 23 Feb 2023 2022 FY
Q4 2019 $235,000 +$235,000 31 Dec 2019 10-K 24 Feb 2022 2021 FY
Q4 2018 $0 $0 31 Dec 2018 10-K 01 Mar 2021 2020 FY
Q3 2018 $0 -$1,500,000 -100% 30 Sep 2018 10-Q 01 Nov 2018 2018 Q3
Q1 2018 $0 -$1,500,000 -100% 31 Mar 2018 10-Q 06 Jul 2018 2018 Q1
Q4 2017 $0 -$1,500,000 -100% 31 Dec 2017 10-K 24 Feb 2020 2019 FY
Q3 2017 $1,500,000 $0 0% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 $1,500,000 -$5,200,000 -78% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $1,500,000 -$4,800,000 -76% 31 Mar 2017 10-Q 05 May 2017 2017 Q1
Q4 2016 $1,500,000 -$1,824,000 -55% 31 Dec 2016 10-K 26 Feb 2019 2018 FY
Q3 2016 $1,500,000 +$1,100,000 +275% 30 Sep 2016 10-Q 04 Nov 2016 2016 Q3
Q2 2016 $6,700,000 30 Jun 2016 10-Q 05 Aug 2016 2016 Q2
Q1 2016 $6,300,000 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 $3,324,000 +$1,824,000 +122% 31 Dec 2015 10-K 06 Jul 2018 2017 FY
Q3 2015 $400,000 -$1,100,000 -73% 30 Sep 2015 10-Q 06 Nov 2015 2015 Q3
Q4 2014 $1,500,000 +$1,500,000 31 Dec 2014 10-K 01 Mar 2017 2016 FY
Q3 2014 $1,500,000 30 Sep 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 $1,522,063 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 $1,522,063 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 $0 31 Dec 2013 10-K 26 Feb 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.